
Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …

Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

